TY - JOUR
T1 - Female adolescents' knowledge and acceptability of human papillomavirus vaccine in Debre Tabor Town, Ethiopia
T2 - a cross-sectional study
AU - Mihretie, Gedefaye Nibret
AU - Liyeh, Tewachew Muche
AU - Ayele, Alemu Degu
AU - Belay, Habtamu Gebrehana
AU - Yimer, Tigist Seid
AU - Miskr, Agernesh Dereje
AU - Kassa, Bekalu Getnet
AU - Tefera, Adanech Getie
AU - Dagnaw, Enyew
AU - Belachew, Yismaw Yimam
AU - Tiruneh, Gebrehiwot Ayalew
AU - Asferi, Worku Necho
AU - Getu, Sisay
AU - Aytenew, Tigabu Munye
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2023/3
Y1 - 2023/3
N2 - Objective This study aimed to assess the knowledge and acceptability of the human papillomavirus (HPV) vaccine and associated factors among female adolescent students in Debre Tabor Town, Ethiopia, 2021. Design Cross-sectional study was done from 9 December 2020 to 28 February 2021. Analysis The data were entered into EpiData V.4.2 and analysed with SPSS V.23 software. The OR, 95% CI and p<0.05 were used to determine the bivariable and multivariable statistical association. Setting Three high schools (grades 9 and 10) and six primary schools (grades 7 and 8) were included in the study. Participants Adolescent female students in Debre Tabor Town. Results The overall knowledge score in the questionnaire was six, and it was divided into two groups based on scoring level: poor (score <3) and good (score ≥3). More than half respondents (59.2%) scored good knowledge. The proportion of acceptability of the HPV vaccine was 61.9%. Age (adjusted OR, AOR 1.70, 95% CI 1.17 to 3.88), and having a source of information (AOR 1.94, 95% CI 1.06 to 3.22) were significantly associated with the knowledge of the HPV vaccine. Place of birth (AOR 1.55, 95% CI 1.15 to 1.95), fathers' educational status (AOR 2.80, 95% CI 1.18 to 5.65), having a source of information (AOR 2.14, 95% CI 1.05 to 4.32) and knowledge about the HPV vaccine (AOR 6.41, 95% CI 3.45 to 11.90) were significantly associated with the acceptance of the female adolescent HPV vaccine. Conclusion In this study, the knowledge and acceptability of students of the HPV vaccine were low. Health authorities, through the mass media, should strengthen HPV vaccine promotion in schools, religious institutions and health facilities.
AB - Objective This study aimed to assess the knowledge and acceptability of the human papillomavirus (HPV) vaccine and associated factors among female adolescent students in Debre Tabor Town, Ethiopia, 2021. Design Cross-sectional study was done from 9 December 2020 to 28 February 2021. Analysis The data were entered into EpiData V.4.2 and analysed with SPSS V.23 software. The OR, 95% CI and p<0.05 were used to determine the bivariable and multivariable statistical association. Setting Three high schools (grades 9 and 10) and six primary schools (grades 7 and 8) were included in the study. Participants Adolescent female students in Debre Tabor Town. Results The overall knowledge score in the questionnaire was six, and it was divided into two groups based on scoring level: poor (score <3) and good (score ≥3). More than half respondents (59.2%) scored good knowledge. The proportion of acceptability of the HPV vaccine was 61.9%. Age (adjusted OR, AOR 1.70, 95% CI 1.17 to 3.88), and having a source of information (AOR 1.94, 95% CI 1.06 to 3.22) were significantly associated with the knowledge of the HPV vaccine. Place of birth (AOR 1.55, 95% CI 1.15 to 1.95), fathers' educational status (AOR 2.80, 95% CI 1.18 to 5.65), having a source of information (AOR 2.14, 95% CI 1.05 to 4.32) and knowledge about the HPV vaccine (AOR 6.41, 95% CI 3.45 to 11.90) were significantly associated with the acceptance of the female adolescent HPV vaccine. Conclusion In this study, the knowledge and acceptability of students of the HPV vaccine were low. Health authorities, through the mass media, should strengthen HPV vaccine promotion in schools, religious institutions and health facilities.
KW - general medicine (see internal medicine)
KW - Gynaecological oncology
KW - Maternal medicine
KW - Public health
KW - Reproductive medicine
UR - http://www.scopus.com/inward/record.url?scp=85150783617&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2022-061813
DO - 10.1136/bmjopen-2022-061813
M3 - Article
C2 - 36948550
AN - SCOPUS:85150783617
SN - 2044-6055
VL - 13
JO - BMJ Open
JF - BMJ Open
IS - 3
M1 - e061813
ER -